AES CORP. DL-,01/ US00130H1059 /
| 2024-07-26 8:02:47 AM | Chg. -0.204 | Volume | Bid8:59:11 PM | Ask8:59:11 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 15.652EUR | -1.29% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 11.47 bill.EUR | - | - |
Newsfile Corp
07-17
Appia Announces Excellent Desorption Results From Target IV Ionic Adsorption Clay Rare Earth Mineral...
GlobeNewswire
07-01
Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studyi...
GlobeNewswire
06-27
Brand Trust Is Higher for Utilities That Spend More on Communication and Highlight Savings and Envir...
GlobeNewswire
06-27
Inmagene Announces Positive Topline Results of a Multiple Ascending Dose (MAD) Study of IMG-004, a N...
GlobeNewswire
06-26
AMERICAN SALARS SUBMITS SAMPLES FOR ASSAY FROM THE NEVADA BLACK ROCK SOUTH LITHIUM BRINE PROJECT
GlobeNewswire
06-25
Tsecond and Carahsoft Partner to Bring Low SWaP, High-Performance Data Solutions for AI, Analytics a...
GlobeNewswire
06-25
Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Tri...
GlobeNewswire
06-24
InflaRx’s GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel ...
GlobeNewswire
06-20
Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose ...
GlobeNewswire
06-20
Aphaia Pharma Announces Positive Results from Phase 2 Trial Evaluating its Lead Drug Formulation for...
GlobeNewswire
06-20
Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potentia...
GlobeNewswire
06-18
XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treat...
GlobeNewswire
06-18
Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low ...
GlobeNewswire
06-17
2024 CSO Award Winners and Hall of Fame Inductees to be Recognized at the CSO Conference & Awards
GlobeNewswire
06-17
FDA Approves Phase II Clinical Trial for Ruxoprubart in ANCA Associated Vasculitis (AAV) – a Chronic...
GlobeNewswire
06-14
Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Associatio...
GlobeNewswire
06-14
Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Tria...
GlobeNewswire
06-13
Lantronix Wins 2024 IoT Evolution Asset Tracking Award for FOX3 Telematic Gateway
GlobeNewswire
06-12
NKGen Biotech Presents Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy for Solid Tumors at ...
